HARVARD BIOSCIENCE, INC. Deferred Revenue Recognized
HARVARD BIOSCIENCE, INC. (HBIO) reported Deferred Revenue Recognized of $1.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2026-08-11
- HARVARD BIOSCIENCE, INC. contract with customer, liability, revenue recognized for the quarter ending 2026-06-30 was $1.00M, a 9.09% decline year-over-year.
- HARVARD BIOSCIENCE, INC. contract with customer, liability, revenue recognized for the quarter ending 2026-03-31 was $1.40M, a 17.65% decline year-over-year.
- HARVARD BIOSCIENCE, INC. contract with customer, liability, revenue recognized for the quarter ending 2025-09-30 was $400.00K, a 0.00% change year-over-year.
- HARVARD BIOSCIENCE, INC. contract with customer, liability, revenue recognized for the quarter ending 2025-06-30 was $1.10M, a 10.00% increase year-over-year.
- HARVARD BIOSCIENCE, INC. contract with customer, liability, revenue recognized for fiscal 2025 was $3.40M, a 0.00% change from fiscal 2024.
- HARVARD BIOSCIENCE, INC. contract with customer, liability, revenue recognized for fiscal 2024 was $3.40M, a 61.90% increase from fiscal 2023.
- HARVARD BIOSCIENCE, INC. contract with customer, liability, revenue recognized for fiscal 2023 was $2.10M, a 16.00% decline from fiscal 2022.
- HARVARD BIOSCIENCE, INC. contract with customer, liability, revenue recognized for fiscal 2022 was $2.50M, a 25.00% increase from fiscal 2021.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 9 month as first filed | Contract with Customer, Liability, Revenue Recognized 12 month | Contract with Customer, Liability, Revenue Recognized 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.00M 10-Q · filed 2026-08-11 | $2.40M 10-Q · filed 2026-08-11 | ||||
| 2026-03-31 | $1.40M 10-Q · filed 2026-05-12 | |||||
| 2025-12-31 | $3.40M 10-K · filed 2026-03-13 | |||||
| 2025-09-30 | $400.00K 10-Q · filed 2025-11-06 | $3.20M 10-Q · filed 2025-11-06 | ||||
| 2025-06-30 | $1.10M 10-Q · filed 2026-08-11 | $2.80M 10-Q · filed 2026-08-11 | ||||
| 2025-03-31 | $1.70M 10-Q · filed 2026-05-12 | |||||
| 2024-12-31 | $3.40M 10-K · filed 2026-03-13 | |||||
| 2024-09-30 | $400.00K 10-Q · filed 2025-11-06 | $3.00M 10-Q · filed 2025-11-06 | ||||
| 2024-06-30 | $1.00M 10-Q · filed 2025-08-11 | $2.60M 10-Q · filed 2025-08-11 | ||||
| 2024-03-31 | $1.60M 10-Q · filed 2025-05-12 | |||||
| 2023-12-31 | $2.10M 10-K · filed 2025-03-14 | |||||
| 2023-09-30 | $1.00M 10-Q · filed 2024-11-08 | $2.30M 10-Q · filed 2024-11-08 | ||||
| 2023-06-30 | $600.00K 10-Q · filed 2024-08-08 | $1.60M 10-Q · filed 2024-08-08 | ||||
| 2023-03-31 | $1.00M 10-Q · filed 2024-05-07 | |||||
| 2022-12-31 | $2.50M 10-K · filed 2024-03-07 | |||||
| 2022-09-30 | $800.00K 10-Q · filed 2023-11-07 | $2.10M 10-Q · filed 2023-11-07 | ||||
| 2022-06-30 | $600.00K 10-Q · filed 2023-08-08 | $1.30M 10-Q · filed 2023-08-08 | ||||
| 2022-03-31 | $700.00K 10-Q · filed 2023-04-26 | |||||
| 2021-12-31 | $2.00M 10-K · filed 2023-03-09 | |||||
| 2021-09-30 | $1.80M 10-Q · filed 2022-11-09 | $1.40M 10-Q · filed 2021-11-05 | ||||
| 2021-06-30 | $300.00K 10-Q · filed 2022-08-04 | $1.50M 10-Q · filed 2022-08-04 | ||||
| 2021-03-31 | $1.20M 10-Q · filed 2022-05-04 | |||||
| 2020-12-31 | $2.00M 10-K · filed 2022-03-11 | $1.70M 10-Q · filed 2021-11-05 | ||||
| 2020-09-30 | $1.43M 10-Q · filed 2020-11-06 | $2.88M 10-Q · filed 2020-11-06 | ||||
| 2020-06-30 | $634.00K 10-Q · filed 2020-08-10 | $1.46M 10-Q · filed 2020-08-10 | ||||
| 2020-03-31 | $821.00K 10-Q · filed 2020-05-08 | |||||
| 2019-12-31 | $3.13M 10-K · filed 2020-03-16 | |||||
| 2019-09-30 | $779.00K 10-Q · filed 2020-11-06 | $2.44M 10-Q · filed 2020-11-06 | ||||
| 2019-06-30 | $594.00K 10-Q · filed 2020-08-10 | $1.67M 10-Q · filed 2020-08-10 | ||||
| 2019-03-31 | $1.07M 10-Q · filed 2020-05-08 | |||||
| 2018-12-31 | $5.16M 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |